Atea Pharmaceuticals (AVIR) Current Leases (2021 - 2026)
Atea Pharmaceuticals (AVIR) recorded quarterly Current Leases of $634000.0 in Q1 2026, down 24.79% quarter-over-quarter from $843000.0 in Q4 2025, and down 21.82% on a YoY basis from $811000.0 in Q1 2025.
Atea Pharmaceuticals (AVIR) Current Leases (2021 - 2026) Analysis & Trends
Atea Pharmaceuticals' Current Leases history runs 6 years deep, the most recent figure standing at $634000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 21.82% year-over-year to $634000.0; the TTM figure through Mar 2026 stood at $634000.0 (down 21.82% YoY), while the FY2025 annual figure was $843000.0, up 5.37% from the prior year.
- Current Leases was $634000.0 for Q1 2026 at Atea Pharmaceuticals, down from $843000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $843000.0 in Q4 2025 to a low of $113000.0 in Q1 2022.
- Historically, Current Leases has averaged $725588.2 across 5 years, with a median of $760000.0 in 2023.
- The sharpest annual moves came in 2023 and 2026: Current Leases soared 546.02% in 2023, then retreated 21.82% in 2026.
- A 5-year view of Current Leases shows it stood at $721000.0 in 2022, then advanced by 5.41% to $760000.0 in 2023, then advanced by 5.26% to $800000.0 in 2024, then grew by 5.38% to $843000.0 in 2025, then declined by 24.79% to $634000.0 in 2026.
- The last three Current Leases figures came in at $634000.0 (Q1 2026), $843000.0 (Q4 2025), and $832000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Atea Pharmaceuticals | 347.28 Mn | 347.28 Mn | - | 634,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 634,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | 832,000.00 |
| Jun 30, 2025 | 821,000.00 |
| Mar 31, 2025 | 811,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 790,000.00 |
| Jun 30, 2024 | 780,000.00 |
| Mar 31, 2024 | 769,000.00 |
| Dec 31, 2023 | 760,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | 740,000.00 |
| Mar 31, 2023 | 730,000.00 |
| Dec 31, 2022 | 721,000.00 |
| Sep 30, 2022 | 711,000.00 |
| Jun 30, 2022 | 730,000.00 |
| Mar 31, 2022 | 113,000.00 |
| Dec 31, 2021 | 197,000.00 |